Global Certificate in Biopharma Drug Discovery
-- ViewingNowThe Global Certificate in Biopharma Drug Discovery is a comprehensive course designed to empower learners with critical skills in drug discovery. This certificate program is crucial in today's biopharma industry, where the demand for skilled professionals is at an all-time high.
2,488+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Drug Discovery Fundamentals: Overview of biopharma drug discovery, including history, current trends, and future directions. This unit will cover the drug discovery process, from target identification to preclinical and clinical development. ⢠Target Identification and Validation: Introduction to the identification of therapeutic targets, including genetic, biochemical, and cellular approaches. This unit will also cover target validation methods and strategies to ensure the suitability of the target for drug development. ⢠High-Throughput Screening (HTS): Overview of HTS, its applications, and limitations. This unit will cover the principles of screening assays, automation technologies, and data analysis techniques. ⢠Lead Optimization: Introduction to lead optimization strategies, including structure-activity relationship (SAR) analysis, medicinal chemistry, and computational approaches. This unit will also cover optimization of pharmacokinetic (PK) and pharmacodynamic (PD) properties. ⢠Preclinical Development: Overview of preclinical development, including in vitro and in vivo testing, pharmacokinetics, and toxicology. This unit will cover regulatory requirements and strategies for successful IND (Investigational New Drug) submission. ⢠Clinical Development: Introduction to clinical development, including Phase I-IV trials, clinical trial design, and regulatory requirements. This unit will also cover biomarkers, surrogate endpoints, and adaptive trial designs. ⢠Intellectual Property (IP) Protection and Commercialization: Overview of IP protection strategies, including patents, trademarks, and trade secrets. This unit will cover technology transfer, licensing, and commercialization of biopharma drugs.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë